BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
-5.04%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.34B
AUM Growth
+$1.34B
(-5.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$6.17M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Staples | 39.99% |
| 2 | Healthcare | 39.26% |
| 3 | Industrials | 11.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$60.9B
| $535M | 39.99% | 9,312,976 | – | – |
|
2
STAAR Surgical
STAA
$1.36B
| $462M | 34.52% | 8,783,082 | – | – |
|
3
Axon Enterprise
AXON
$58.7B
| $148M | 11.09% | 760,062 | – | – |
|
4
iShares Russell 2000 ETF
IWM
$67B
| $129M | 9.66% | 690,000 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $49.3M | 3.68% | 34,935,485 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $11.5M | 0.86% | 50,181,335 +26,827,638 | +115% | +$6.17M |
|
7
Serina Therapeutics
SER
$54.5M
| $2.68M | 0.2% | 2,997,156 | – | – |
|